Low-dose methotrexate in myeloproliferative neoplasm models. (2017)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2017.165738
PubMed Identifier: 28550185
Publication URI: http://europepmc.org/abstract/MED/28550185
Type: Journal Article/Review
Volume: 102
Parent Publication: Haematologica
Issue: 9
ISSN: 0390-6078